What is the recommended infusion rate and duration for administering 40g of albumin to a patient with spontaneous bacterial peritonitis (SBP) and significant ascitic fluid drainage, likely due to cirrhosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Administration Protocol for Spontaneous Bacterial Peritonitis

Direct Answer

For a patient with SBP and significant ascitic fluid drainage, administer 1.5 g/kg albumin within the first 6 hours of diagnosis, followed by 1 g/kg on day 3—this is a TWO-DOSE protocol only, with no additional albumin needed after day 3 unless there are other specific indications. 1

Dosing Algorithm for 40g Albumin Example

If your patient requires approximately 40g of albumin (suggesting a body weight around 27-40 kg for the first dose):

Day 1 Dose (1.5 g/kg):

  • Infusion rate: The guidelines specify administration within the first 6 hours of SBP diagnosis 1
  • For 40g albumin: Infuse over 6 hours maximum
  • Per hour rate: Approximately 6.7g/hour (or 33 mL/hour if using 20% albumin solution) 1

Day 3 Dose (1 g/kg):

  • Amount: Approximately 27g for the same patient
  • Infusion duration: Can be given over 6 hours 1
  • Per hour rate: Approximately 4.5g/hour

Critical Timing Point:

The first dose MUST be given within 6 hours of SBP diagnosis—this timing is crucial for preventing hepatorenal syndrome and reducing mortality. 1, 2

Duration of Therapy: Only 2 Doses Total

You give albumin on TWO days only: Day 1 (at diagnosis) and Day 3—then STOP. 1 There is no continuation beyond day 3 for SBP treatment. This is not a daily or ongoing therapy.

The protocol is specifically:

  • Day 1: 1.5 g/kg within first 6 hours of diagnosis 1
  • Day 3: 1 g/kg 1
  • Days 2,4,5+: No albumin (unless other indications exist)

Evidence for This Specific Regimen

This two-dose protocol reduced mortality from 29% to 10% and decreased hepatorenal syndrome from 30% to 10% in the landmark randomized controlled trial. 1 The European Association for the Study of the Liver gives this a Level A1 recommendation—the highest grade of evidence. 1

When to Use This Protocol

Albumin is particularly beneficial in high-risk SBP patients with:

  • Serum bilirubin ≥4 mg/dL (68 μmol/L) 1
  • Serum creatinine ≥1 mg/dL (88 μmol/L) 1

For patients with bilirubin <4 mg/dL AND creatinine <1 mg/dL, the benefit is less clear (hepatorenal syndrome risk was only 7% without albumin vs 0% with albumin), but current guidelines still recommend albumin for all SBP patients. 1

Important Safety Considerations

Infusion Rate Warning:

A critical 2023 study found that the standard dose albumin (1.5 g/kg) infused over 6 hours caused symptomatic circulatory overload in 100% of patients, requiring premature cessation. 3 This suggests:

  • Consider slower infusion over 8-12 hours for the first dose to prevent pulmonary edema, especially in patients with baseline cardiac dysfunction 1, 3
  • Monitor closely for respiratory distress during infusion 3
  • Stop infusion immediately if pulmonary edema develops 3

Pulmonary Edema Risk:

Albumin administration carries an 8.3% risk of pulmonary edema in critically ill cirrhotic patients, which can be fatal. 4 This risk is higher with:

  • Higher MELD scores 4
  • Pre-existing cardiac dysfunction 1
  • Rapid infusion rates 1, 3

What NOT to Do

Do NOT use albumin for infections other than SBP—a 2015 randomized trial showed no survival benefit and increased pulmonary edema risk (8.3%) in non-SBP infections. 4

Do NOT continue albumin beyond day 3 for SBP treatment—there is no evidence supporting extended therapy, and it increases cost and complication risk without benefit. 1

Do NOT use albumin for routine ascites management without large-volume paracentesis or SBP—it provides no mortality benefit in uncomplicated ascites. 5, 2

Alternative Dosing Consideration

One 2019 study used a lower dose protocol (30g on day 1 and day 3, regardless of weight) with acceptable outcomes: 18.3% hepatorenal syndrome rate and 4% immediate mortality. 6 However, this contradicts the weight-based dosing in major guidelines and should only be considered if standard dosing causes intolerable side effects. 1

Summary of Your Specific Question

For your 40g albumin dose:

  • Hour 1-6: Infuse the 40g (if this represents your day 1 dose of 1.5 g/kg)
  • Day 3: Give second dose of 1 g/kg (approximately 27g for same patient)
  • After day 3: STOP albumin—no further doses needed for SBP treatment 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Use of Albumin in Patients with Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Tolerance of standard dose albumin infused over 6 hrs for treatment of spontaneous bacterial peritonitis-A randomized controlled trial.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2023

Guideline

Management of Uncomplicated Cirrhotic Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Effect of low dose albumin administration in spontaneous bacterial peritonitis on renal function and survival.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.